Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Methylation status plays a causal role in carcinogenesis in targeted tissues. However, the relationship between the DNA methylation status of multiple genes in blood leukocytes and colorectal cancer (CRC) susceptibility as well as interactions between dietary factors and CRC risks are unclear. Methods: We performed a case-control study with 466 CRC patients and 507 cancer-free controls to investigate the association among the methylation status of individual genes, multiple CpG site methylation (MCSM), multiple CpG site heterogeneous methylation and CRC susceptibility. Peripheral blood DNA methylation levels were detected by performing methylation-sensitive high-resolution melting. Results: Total heterogeneous methylation of CA10 and WT1 conferred a significantly higher risk of CRC (adjusted odds ratio [ORadjusted], 5.445; 95% confidence interval [CI], 3.075 to 9.643; ORadjusted, 1.831; 95% CI, 1.100 to 3.047; respectively). Subjects with high-level MCSM (MCSM-H) status demonstrated a higher risk of CRC (ORadjusted, 4.318; 95% CI, 1.529 to 12.197). Additionally, interactions between the high-level intake of fruit and CRH, WT1, and MCSM on CRC were statistically significant. Conclusions: The gene methylation status of blood leukocytes may be associated with CRC risk. MCSM-H of blood leukocytes was associated with CRC, especially in younger people. Some dietary factors may affect hypermethylation status and influence susceptibility to CRC.
Abstract
Background/Aims: Methylation status plays a causal role in carcinogenesis in targeted tissues. However, the relationship between the DNA methylation status of multiple genes in blood leukocytes and colorectal cancer (CRC) susceptibility as well as interactions between dietary factors and CRC risks are unclear. Methods: We performed a case-control study with 466 CRC patients and 507 cancer-free controls to investigate the association among the methylation status of individual genes, multiple CpG site methylation (MCSM), multiple CpG site heterogeneous methylation and CRC susceptibility. Peripheral blood DNA methylation levels were detected by performing methylation-sensitive high-resolution melting. Results: Total heterogeneous methylation of CA10 and WT1 conferred a significantly higher risk of CRC (adjusted odds ratio [ORadjusted], 5.445; 95% confidence interval [CI], 3.075 to 9.643; ORadjusted, 1.831; 95% CI, 1.100 to 3.047; respectively). Subjects with high-level MCSM (MCSM-H) status demonstrated a higher risk of CRC (ORadjusted, 4.318; 95% CI, 1.529 to 12.197). Additionally, interactions between the high-level intake of fruit and CRH, WT1, and MCSM on CRC were statistically significant. Conclusions: The gene methylation status of blood leukocytes may be associated with CRC risk. MCSM-H of blood leukocytes was associated with CRC, especially in younger people. Some dietary factors may affect hypermethylation status and influence susceptibility to CRC.
참고문헌 (43)
- Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)[DOI]
- Grady WM, "Genomic and epigenetic instability in colorectal cancer pathogenesis", Gastroenterology, 135, pp.1079~1099 (2008)[DOI]
- Storosum JG, "Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia", Arch Gen Psychiatry, 60, pp.365~368 (2003)[DOI]
- Wong JJ, "Colorectal cancer: a model for epigenetic tumorigenesis", Gut, 56, pp.140~148 (2007)[DOI]
- Sakai E, "Accumulation of aberrant DNA methylation during colorectal cancer development", World J Gastroenterol, 20, pp.978~987 (2014)[DOI]
- Oji Y, "Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma", Cancer Sci, 94, pp.712~717 (2003)[DOI]
- Hiltunen MO, "Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer", Br J Cancer, 76, pp.1124~1130 (1997)[DOI]
- Huang KT, "Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer", Breast Cancer Res Treat, 130, pp.319~329 (2011)[DOI]
- Pan X, "Methylation of the corticotropin releasing hormone gene promoter in BeWo cells: relationship to gene activity", Int J Endocrinol, 2015, pp.861302~ (2015)
- Aspatwar A, "An update on carbonic anhydrase-related proteins VIII, X and XI", J Enzyme Inhib Med Chem, 28, pp.1129~1142 (2013)[DOI]
- Ruiz S, "Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells", Proc Natl Acad Sci U S A, 109, pp.16196~16201 (2012)[DOI]
- Bejrananda T, "WT1 expression as an independent marker of poor prognosis in colorectal cancers", Cancer Biomark, 8, pp.35~42 (2011)[DOI]
- Tews B, "Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q", Oncogene, 26, pp.5010~5016 (2007)[DOI]
- Fukudo S, "Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation", J Gastroenterol, 42(Suppl 17), pp.48~51 (2007)[DOI]
- 임은옥, "Corticotropin-releasing Hormone and Its Biological Diversity toward Angiogenesis", Intestinal research, 12(2), pp.96~102 (2014), 대한장연구학회
- Wojdacz TK, "Identification and characterization of locus-specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis", Breast Cancer Res, 16, pp.R17~ (2014)[DOI]
- Chung W, "Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments", Cancer Epidemiol Biomarkers Prev, 20, pp.1483~1491 (2011)[DOI]
- Erhardt A, "Replication and meta-analysis of TMEM132D gene variants in panic disorder", Transl Psychiatry, 2, pp.e156~ (2012)[DOI]
- Nomoto H, "Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes", J Biochem, 134, pp.231~238 (2003)[DOI]
- Gonzalez CA, "Diet and cancer prevention: contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study", Eur J Cancer, 46, pp.2555~2562 (2010)[DOI]
- Armaghany T, "Genetic alterations in colorectal cancer", Gastrointest Cancer Res, 5, pp.19~27 (2012)
- Sarasqueta AF, "Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer", BMC Cancer, 13, pp.277~ (2013)[DOI]
- Azhikina T, "Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues", Cancer Genet, 204, pp.492~500 (2011)[DOI]
- Candiloro IL, "Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene", Epigenetics Chromatin, 1, pp.7~ (2008)[DOI]
- Kristensen LS, "Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM", BMC Cancer, 9, pp.453~ (2009)[DOI]
- Lim AM, "Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome", Clin Epigenetics, 6, pp.22~ (2014)[DOI]
- Pisanic TR 2nd, "Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity", Semin Cell Dev Biol, 64, pp.5~17 (2017)[DOI]
- Ambatipudi S, "Tobacco smoking-associated genome-wide DNA methylation changes in the EPIC study", Epigenomics, 8, pp.599~618 (2016)[DOI]
- Zheng SC, "Epigenetic drift, epigenetic clocks and cancer risk", Epigenomics, 8, pp.705~719 (2016)[DOI]
- Marsit C, "Blood-derived DNA methylation markers of cancer risk", Adv Exp Med Biol, 754, pp.233~252 (2013)
- Dauksa A, "DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer", Anticancer Res, 34, pp.5381~5388 (2014)
- Woo HD, "Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis", PLoS One, 7, pp.e34615~ (2012)[DOI]
- Luo X, "Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer", Sci Rep, 6, pp.29922~ (2016)[DOI]
- Koestler DC, "Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers", Cancer Epidemiol Biomarkers Prev, 21, pp.1293~1302 (2012)[DOI]
- Mikeska T, "The implications of heterogeneous DNA methylation for the accurate quantification of methylation", Epigenomics, 2, pp.561~573 (2010)[DOI]
- Wojdacz TK, "Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies", Expert Rev Mol Diagn, 10, pp.575~580 (2010)[DOI]
- Wang Q, "Heterogeneous DNA methylation contributes to tumorigenesis through inducing the loss of coexpression connectivity in colorectal cancer", Genes Chromosomes Cancer, 54, pp.110~121 (2015)[DOI]
- Kim YI, "Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility", J Nutr, 135, pp.2703~2709 (2005)[DOI]
- Zhu K, "Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes", Cancer Causes Control, 14, pp.827~836 (2003)[DOI]
- Larsson BK, "Formation of polycyclic aromatic hydrocarbons during the smoking and grilling of food", Prog Clin Biol Res, 206, pp.169~180 (1986)
- Tretyakova N, "Endogenous cytosine methylation and the formation of carcinogen carcinogen-DNA adducts", Nucleic Acids Symp Ser (Oxf), (52), pp.49~50 (2008)
- Fardet A, "New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?", Nutr Res Rev, 23, pp.65~134 (2010)
- Wojdacz TK, "Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation", Nucleic Acids Res, 35, pp.e41~ (2007)[DOI]
